2025-12-23 - Analysis Report
Okay, let's break down the analysis of Procter & Gamble (PG) step-by-step.

**0) Introduction**

This report analyzes Procter & Gamble (PG) based on its recent performance, comparing it to the S&P 500 (VOO), and taking into account technical indicators, news, analyst opinions, and financial data.

**1) Performance Comparison: PG vs. S&P 500 (VOO)**

*   **Company Overview:** Procter & Gamble Co. is a multinational consumer goods corporation.
*   **PG Cumulative Return:** 26.13%
*   **VOO Cumulative Return:** 100.88%
*   **Divergence:** -74.8 (Relative Divergence: 5.3)

**Analysis:**

PG has significantly underperformed the S&P 500 based on the provided cumulative return data. The divergence of -74.8 indicates a substantial gap in performance. A relative divergence of 5.3 suggests that the current divergence is near the lower end of its historical range. This could mean there's potential for PG to catch up, but it could also indicate a persistent trend of underperformance.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 21.0% | 7.9% | -8.0% | 0.0 | 212.4 |
| 2016-2018  | 9.0% | 67.3% | -6.0% | 0.1 | 212.5 |
| 2017-2019  | 24.0% | 70.4% | 2.0% | 0.3 | 288.7 |
| 2018-2020  | 27.0% | 78.8% | 4.0% | 0.4 | 321.7 |
| 2019-2021  | 41.0% | 78.8% | -5.0% | 0.5 | 378.2 |
| 2020-2022  | 13.0% | 79.4% | 13.0% | 0.6 | 350.4 |
| 2021-2023  | 26.0% | 79.4% | 24.0% | 0.4 | 338.8 |
| 2022-2024  | 9.0% | 79.4% | -12.0% | 0.4 | 387.6 |
| 2023-2025  | -18.0% | 80.1% | -83.0% | 0.1 | 334.0 |

*   **CAGR (Compound Annual Growth Rate):** Varies significantly across periods, ranging from -18% to 41%.  The most recent period shows a negative growth rate.
*   **MDD (Maximum Drawdown):** The MDD figures are consistently high, indicating significant potential for losses over these periods.
*   **Alpha:**  Alpha measures the stock's performance relative to its beta.  Negative alpha indicates underperformance compared to what would be expected based on its beta. Positive alpha indicates overperformance.  The recent period (2023-2025) shows a very large negative alpha.
*   **Beta:** Beta is generally low, close to 0, suggesting PG's price is not strongly correlated with the market.
*   **Cap(B) (Market Cap in Billions):**  The company's market capitalization has fluctuated.

**2) Recent Stock Price Fluctuations:**

*   **Current Price:** 144.46
*   **Last Market Data:** Price = 142.69, Previous Close = 144.46, Change = -1.23
*   **5-day SMA:** 145.626
*   **20-day SMA:** 144.9054
*   **60-day SMA:** 148.0645

**Analysis:**

The stock price is slightly below its 5-day and 20-day SMAs but significantly below its 60-day SMA. This suggests a recent downtrend.  The last market data indicates a decrease in price compared to the previous close.

**3) Technical Indicators and Signals:**

*   **Market Risk Indicator (MRI):** 0.8 (Medium Investment)
*   **RSI:** 47.18 (Neutral)
*   **PPO:** 0.3263
*   **Hybrid Signal:**  Cash_0%_Buy 100% of cash (7 shares - Very Safe - MRI:0.90) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent Relative Divergence Change (20 days):** 1.0 (+): 단기상승 (Short-term increase)
*   **Expected Return (%):** -0.5

**Analysis:**

*   The MRI suggests a medium level of investment risk.
*   The RSI is near the middle range, indicating neither overbought nor oversold conditions.
*   The PPO is positive but low.
*   The hybrid signal suggests a buy recommendation, characterizing the stock as "Very Safe" with an MRI of 0.90.  It's important to note the discrepancy between the general MRI (0.8) and the MRI used in the hybrid signal (0.90).
*   The recent relative divergence change points to a short-term upward movement.
*   The expected return is slightly negative (-0.5%), suggesting potential underperformance compared to the S&P 500 over the long term.

**4) Recent News & Significant Events:**

*   **Key Themes:**
    *   Analysis of PG's historical performance ("How Good Has PG Stock Actually Been?").
    *   Outlook and factors that could influence PG shares ("Procter & Gamble Stock (NYSE: PG) Week-Ahead Outlook").
    *   Reactions to PG's influencer marketing and leadership transition ("How Investors Are Reacting To Procter & Gamble (PG) Influencer Push And Leadership Transition").
    *   Positive mention by Jim Cramer as a favorite stock.
    *   Analysis of PG's Q1 FY26 earnings and price decline ("Procter & Gamble Stock (PG) Opinions on Q1 FY26 Earnings and Price Decline").

**Analysis:**

The news articles present a mixed picture. Some articles focus on long-term performance, while others address recent events like earnings, marketing strategies, and leadership changes. The mention by Jim Cramer is generally a positive signal. Concerns about earnings and price decline are negative signals. The article on investor reaction to marketing and leadership changes could indicate uncertainty in the market.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (Mean: 1.92)
*   **Opinions:** 22
*   **Target Price:**
    *   Average: 168.95
    *   High: 186.00
    *   Low: 148.00
*   **Recent Rating Changes:** (No changes mentioned)

**Analysis:**

Analysts, on average, have a "Buy" rating for PG. The average target price is significantly higher than the current price, suggesting potential upside. The absence of recent rating changes indicates a relatively stable outlook from analysts.

**5) Recent Earnings Analysis:**

| 날짜         | EPS  | 매출        |
|-------------|------|-------------|
| 2025-10-24 | 2    | 22.39 B$    |
| 2025-04-24 | 1.58 | 19.78 B$    |
| 2025-01-22 | 1.94 | 21.88 B$    |
| 2024-10-18 | 1.65 | 21.74 B$    |
| 2025-10-24 | 1.65 | 21.74 B$    |

**Analysis:**

The data shows fluctuating EPS and revenue figures.
*   Q3 2025 has an EPS of 2 and Revenue of 22.39B
*   Q2 2025 has an EPS of 1.58 and Revenue of 19.78B
*   Q1 2025 has an EPS of 1.94 and Revenue of 21.88B

The Q3 data is identical to Q1 2024. This is either a data error or repetition. The numbers are fluctuating but show revenue generally in the range of 20-22B.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|----------------|
| 2025-09-30   | $22.39B    | 51.37%         |
| 2025-06-30   | $20.89B    | 49.11%         |
| 2025-03-31   | $19.78B    | 50.98%         |
| 2024-12-31   | $21.88B    | 52.39%         |
| 2024-09-30   | $21.74B    | 52.06%         |

**Analysis:**

Revenue has fluctuated between $19.78B and $22.39B over the last five quarters. Profit margins are consistently high, ranging from 49.11% to 52.39%, indicating strong profitability.

**Capital and Profitability:**

| Quarter      | Equity     | ROE       |
|--------------|------------|-----------|
| 2025-09-30   | $53.27B    | 8.92%     |
| 2025-06-30   | $52.01B    | 6.95%     |
| 2025-03-31   | $52.27B    | 7.21%     |
| 2024-12-31   | $51.17B    | 9.05%     |
| 2024-09-30   | $51.84B    | 7.64%     |

**Analysis:**

Equity has steadily increased over the past five quarters. ROE (Return on Equity) has fluctuated, indicating varying levels of profitability relative to shareholder equity. ROE is relatively strong, generally above 7%.

**7) Comprehensive Analysis (Summary)**

*   **Underperformance:** PG has significantly underperformed the S&P 500 in terms of cumulative return.
*   **Downtrend:** Recent price action suggests a downtrend, with the price below its 60-day SMA.
*   **Mixed Signals:** Technical indicators provide mixed signals. The RSI is neutral, but the recent divergence change suggests a short-term upward movement. The hybrid signal gives a buy signal but uses a higher MRI than the general MRI, which is a potential discrepancy.
*   **Analyst Optimism:** Analysts have a "Buy" consensus and a target price significantly above the current price, suggesting potential upside.
*   **Financial Strength:** PG shows strong profitability with high profit margins and ROE.
*   **News Uncertainty:** Recent news covers various aspects, including historical performance, marketing strategies, and earnings, presenting a mix of positive and negative signals.

**Overall Conclusion:**

While PG exhibits financial strength and analyst optimism, its underperformance compared to the S&P 500 and recent downtrend raise concerns. The data presents a complex picture, warranting further investigation before making an investment decision. Consider carefully the negative expected return and the risks highlighted by the MDD values.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.